Can a single model explain both breast cancer and prostate cancer?

被引:12
|
作者
Friedman, A. Edward [1 ]
机构
[1] Univ Chicago, Dept Math, Chicago, IL 60637 USA
来源
THEORETICAL BIOLOGY AND MEDICAL MODELLING | 2007年 / 4卷
关键词
D O I
10.1186/1742-4682-4-28
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background: The Estradiol-Dihydrotestosterone model of prostate cancer (PC) showed how the interaction of hormones with specific hormone receptors affected apoptosis. The same hormone can produce different effects, depending on which hormone receptor it interacts with. Model: This model proposes that the first step in the development of most PC and breast cancer (BC) occurs when aromatase converts testosterone to estradiol (E2). A sufficiently high enough local level of E2 results in telomerase activity. The telomerase activity allows cell division and may lead to BC or PC, which will proliferate if the rate of cell division is greater than the rate of cell death. The effect of hormones on their hormone receptors will affect the rate of cell death and determine whether or not the cancer proliferates. Conclusion: By minimizing bcl-2 and maximizing apoptotic proteins, new systemic treatments for BC and PC can be developed that may be more effective than existing treatments.
引用
收藏
页数:13
相关论文
共 50 条
  • [41] Re: Rethinking Screening for Breast Cancer and Prostate Cancer
    Herr, Harry W.
    EUROPEAN UROLOGY, 2010, 57 (03) : 540 - 540
  • [42] Rethinking Screening for Breast Cancer and Prostate Cancer Comment
    Walsh, Patrick C.
    JOURNAL OF UROLOGY, 2010, 183 (04): : 1384 - 1385
  • [43] Treatment effect of breast cancer and prostate cancer on bone
    Varsavsky, Mariela
    Guadalix Iglesias, Sonsoles
    MEDICINA CLINICA, 2013, 140 (04): : 164 - 168
  • [44] The Role of Isoflavones in the Prevention of Breast Cancer and Prostate Cancer
    Pejcic, Tomislav
    Zekovic, Milica
    Bumbasirevic, Uros
    Kalaba, Milica
    Vovk, Irena
    Bensa, Maja
    Popovic, Lazar
    Tesic, Zivoslav
    ANTIOXIDANTS, 2023, 12 (02)
  • [45] The antihormonal preventive therapy of breast cancer and prostate cancer
    Senn, Hans-Joerg
    Morant, Rudolf
    Otto, Florian
    HORMONE MOLECULAR BIOLOGY AND CLINICAL INVESTIGATION, 2011, 5 (02) : 117 - 123
  • [46] Rethinking screening for breast cancer and prostate cancer.
    Jeanine Genkinger
    中国肿瘤临床, 2010, 37 (02) : 124 - 125
  • [47] Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening
    Lee, U. J.
    Jones, J. S.
    PROSTATE CANCER AND PROSTATIC DISEASES, 2009, 12 (01) : 52 - 56
  • [48] Incidence of prostate cancer in male breast cancer patients: a risk factor for prostate cancer screening
    U J Lee
    J S Jones
    Prostate Cancer and Prostatic Diseases, 2009, 12 : 52 - 56
  • [49] Can breast cancer be reirradiated?
    Pinar Sedeno, Maria Beatriz
    Calin Lorca, Ana
    Garcia Cabrera, Laura
    REVISTA DE SENOLOGIA Y PATOLOGIA MAMARIA, 2023, 36
  • [50] Can breast cancer be prevented?
    Boons, CW
    ANNALS OF SAUDI MEDICINE, 1999, 19 (03) : 276 - 276